# Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure

> **NCT00585546** · PHASE1 · TERMINATED · sponsor: **Francis D. Pagani** · enrollment: 18 (actual)

## Conditions studied

- Heart Failure
- Dilated Cardiomyopathy

## Interventions

- **DRUG:** clenbuterol

## Key facts

- **NCT ID:** NCT00585546
- **Lead sponsor:** Francis D. Pagani
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** No longer could obtain clenbuterol
- **Last updated:** 2017-12-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585546, "Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00585546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*